Why Some Medications Need to Be Tapered – and What Can Happen If You Stop Suddenly

You remember a time when you went to the doctor and were diagnosed with depression. You recall not really wanting to answer anyone’s phone calls, sleeping more often, and losing interest in your hobbies. After the diagnosis, your physician gave you a prescription for an antidepressant, which you reluctantly start taking, as you’re not really a person who likes taking medications. One day, you realize that you are feeling much better, and consider stopping because you prefer not to take drugs if you don’t have to. Then, you start to think if it’s okay to abruptly quit today or if you should create a plan with your physician to reduce the medication frequency first.

Introduction

While it is tempting to assume that discontinuing a medication is safe when you are feeling better, it is important to be aware that it could be potentially dangerous. Many medications could be stopped suddenly; however, there are many that could cause potential risks if abruptly discontinued. Suddenly stopping could potentially lead to withdrawal, rebound effects, or the return of the underlying condition.

Withdrawal is the presence of symptoms due to stopping or reducing a medication. Rebound occurs when the original physiological effect temporarily returns stronger than before. The underlying condition can even possibly occur after abruptly stopping a medication. This is when the illness or symptoms that the medication was treating come back.

Throughout this post, we will go over the importance of tapering some medications. Not all medications can be discontinued at that very moment, and doing so may lead to consequences. Bodies sometimes need time to adjust to the reduction of certain drugs, so it is important to follow recommendations. Never stop or change a prescribed medication without talking to your healthcare professional.

Stopping vs. tapering a medication

What does “Tapering” a Medication Mean?

The process of medication tapering involves gradually reducing the medication dose and/or changing the frequency. This reduction can occur over days, weeks, or even months, depending on the medication and the patient’s response. There isn’t just one tapering schedule for medications. Medical professionals decide on the tapering schedule by considering:

  • The medication characteristics of both the medication desired to be tapered and others that the patient is prescribed
  • Duration of the treatment
  • The current dose the patient is taking
  • The patient’s medical history
  • If there were previous attempts to taper, and the results of them
  • Symptoms felt during dose reductions, either at the current time or at prior times
  • If the slower taper is more appropriate

Why Does the Body Sometimes Need Time to Adjust?

Various factors determine how a patient’s body will adjust to a drug taper. Receptor adaptation, neurotransmitter changes, or other changes in the signaling system are examples of why the body needs time to adjust. Another reason is due to hormonal suppression.

Additionally, when the body is used to having a medication present daily, it could be difficult for the body to adjust to a reduced dose. The half-life of the drug could greatly influence this factor. It is very important to think about why suddenly removing the medication can temporarily disrupt those systems. The goal should be to shorten or eliminate the disruptions or risks associated with tapering the drug.

Long-term use of pain medication is an example of a situation where the body might be used to the drug and will require monitoring when tapering down. Nearly one-third of patients who are chronically experiencing pain and don’t have cancer are prescribed pain medication on an ongoing basis. Pain medication tapering, or PMT, is the current recommendation to safely taper the drug. This helps mitigate the risk of their long-term use (Wuyts et al., 2024).

Withdrawal vs. Rebound vs. Return of the Original Conditions

Withdrawal, rebound, and return of the original conditions are potential risks associated with abruptly stopping a medication. These could still occur even with safe tapering; however, with physician oversight, the severity can be manageable.  

Withdrawal

As mentioned earlier, withdrawal describes the symptoms caused by stopping or reducing a medication. While withdrawal symptoms vary widely depending on the medication, some forms of withdrawal can be medically serious or even life-threatening. The tapering of benzodiazepines (BZDs) commonly needs to be closely monitored due to serious or potentially life-threatening withdrawal symptoms. They are used to treat conditions such as anxiety and panic disorders, social phobia, insomnia, and seizures (Brunner et al., 2025).  There are numerous adverse events associated with the use of BZDs, including falls, motor vehicle accidents, cognitive impairment, delirium, overdose, and death, making the risk-benefit balance vital. This balance could be different for the same patient at different times, taking their mental health and other prescribed medications into consideration. Physical dependence, withdrawals, and ongoing risks for adverse events have been associated with long-term use (Brunner et al., 2025).  

Rebound

Rebound occurs when a symptom or physiological effect that a medication was controlling returns temporarily and may be more intense than it was before treatment. Common examples include rebound hypertension after stopping blood pressure medications or rebound insomnia after stopping sleep medications.

Return of the Underlying Condition

There is a risk of the underlying condition returning when stopping a medication. For example, someone taking an antidepressant may begin feeling better because the medication is controlling their symptoms. If they stop taking it, their original symptoms may eventually return.

BZDs can also fall into this category of potential effects of tapering/discontinuing medications. Patients who stop taking BZDs are also at risk of recurrence and exacerbation of the symptoms they had before (Brunner et al., 2025).

Which Medications Commonly Require Tapering?

Not all medications need tapering, but there are a few categories that are best to taper off. The first example is corticosteroids. Long-term use can suppress the body’s natural cortisol production, which can lead to dangerous consequences if stopped abruptly. Discontinuing antidepressants can cause dizziness, nausea, sleep changes, sensory disturbances, and mood changes. The presence of these symptoms is not a sign of addiction, and it is very important to know the distinction between addiction and discontinuation symptoms. Use of benzodiazepines can cause physical dependence, leading to potential danger when abruptly discontinuing. A possible danger is an increased risk of seizures, making it vital to have medically supervised tapering. Lastly, if someone suddenly stops taking a beta blocker, they may experience rebound effects. A provider will closely monitor anyone tapering a medication, as patients may react differently to different medications.

What Can Happen if You Stop Suddenly?

Reactions to abruptly stopping a medication can vary greatly depending on the patient, the drug, and how long the drug has been taken, ranging from mild to moderate to potentially serious. Possible examples of reactions include dizziness, nausea, headache, insomnia, anxiety, irritability, sweating, flu-like feelings, changes in blood pressure or heart rate, or return/worsening of the original symptoms.

Why Can’t Everyone Use the Same Tapering Schedule and How do Healthcare Professionals Decide on the Taper

Factors that affect the determined tapering schedule include:

  • The medication
  • The dose
  • How long the drug was taken
  • Frequency of dosing
  • Half-life
  • Formulation
  • Previous withdrawal symptoms and how the patient responds during the taper

A healthcare provider will monitor symptoms the patient is experiencing to try to give more comfort and check for safety. They might also decide to taper slowly if it seems to be more appropriate.

For example, tapering BZDs can be challenging to do safely, as rapid dosage reductions may lead to potential life-threatening withdrawal. Before beginning to taper off BZDs, the physician should perform a medication and health review for anything that could be impacted by the taper. If needed, they can consider the lower end of the dose reduction range (Brunner et al., 2025).

Conclusion

Feeling better after a medication is good, and it’s tempting to abruptly stop it. However, in some cases, suddenly stopping a medication dangerous. Depending on the medication, abruptly discontinuing treatment can lead to withdrawal symptoms, rebound effects, or the return or worsening of the condition being treated.

Tapering allows the body time to adjust to changes in medication exposure and allows healthcare professionals to monitor for symptoms and make adjustments when necessary. The appropriate tapering schedule will vary from person to person and depends on factors such as the medication, dose, duration of treatment, formulation, and the patient’s response.

Talk with your physician, pharmacist, or other qualified healthcare professional about the safest approach if you would like to discontinue a medication. A drug may no longer be necessary, but determining how and when to discontinue it is an important part of safe medication use.

Ultimately, tapering is not about staying on a medication indefinitely. It is about giving the body the time it may need to adjust safely.

References

Brunner, E., Chen, C. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., Sanders, A. E., Snodgrass, B., VandenBerg, A., Wright, T., Boyle, M., Devoto, A., Framnes-DeBoer, S., Kleykamp, B., Norrington, J., . . . Contractors. (2025). Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits. J Gen Intern Med, 40(12), 2814-2859. https://doi.org/10.1007/s11606-025-09499-2

Wuyts, E., Goudman, L., Crunelle, C. L., Merlano Gomez, M., Putman, K., Bultinck, F., Pilitsis, J. G., & Moens, M. (2024). Effectiveness of pain medication tapering in chronic pain patients: a systematic review and meta-analysis. Br J Anaesth, 133(5), 998-1020. https://doi.org/10.1016/j.bja.2024.07.025

Author Bio

I am a healthcare professional and pharmacy technician with experience in pharmacy practice and medication-related topics. I am passionate about medication safety, healthcare education, and making complex healthcare information easily accessible. Through TheMedDose, I share practical insights on medications, pharmacy practice, and patient safety to help the public better understand the impact of medications in everyday care.

Leave a Comment

Your email address will not be published. Required fields are marked *